Therapeutic effects of physostigmine during systemic inflammation
Katharina Effenberger-Neidnicht,1 Johannes Jägers,2 Rabea Verhaegh,1 Michael Kirsch1 1Institute of Physiological Chemistry, University Hospital Essen, Essen, Germany; 2Institute of Physiology, University Hospital Essen, Essen, Germany Introduction: Usually, physostigmine is used as antidote...
Enregistré dans:
Auteurs principaux: | Effenberger-Neidnicht K, Jägers J, Verhaegh R, Kirsch M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c9c7f94bbb89450a839cbe4c6d2aba92 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Moderate glucose supply reduces hemolysis during systemic inflammation
par: Jägers J, et autres
Publié: (2018) -
Microvascular stasis and hemolysis: coincidence or causality?
par: Effenberger-Neidnicht K, et autres
Publié: (2019) -
Screening of Key Genes of Sepsis and Septic Shock Using Bioinformatics Analysis
par: Zeng X, et autres
Publié: (2021) -
PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
par: Wasyluk W, et autres
Publié: (2021) -
Circulating Neutrophil-Derived Microparticles Associated with the Prognosis of Patients with Sepsis
par: Chen HP, et autres
Publié: (2020)